IP Verse

Lonza Biologics Plc. opposition analysis

COMPANY ANALYSIS

Patent:

Grant Date:

Jan 27, 2021

Title:

High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell

Oppositions:

Patent:

Grant Date:

Jan 24, 2018

Title:

Variant Immunoglobulins With Improved Manufacturability

Oppositions:

Patent Number	Grant Date	Title	Total Oppositions
EP1915394	Jan 27, 2021	High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell	6
EP2467400	Jan 24, 2018	Variant Immunoglobulins With Improved Manufacturability	2

EUROPEAN OPPOSITIONS LIMITED

LASAR, ANDREA

MAIWALD GMBH

Feel free to send us a message here and we will get back to you